Change of executive director
Filed with HKEX · Stock code 2487 · · 3 pages · English
Earlier from Cutia Therapeutics
- 2026 Interim Report
- Voluntary announcement - CU-40102 (topical finasteride spray) obtained marketing approval by the macao pharmaceutical administration bureau
- Poll results of the annual general meeting held on 26 June 2026
Later from Cutia Therapeutics
- List of directors and their roles and functions
- Voluntary announcement - share repurchase program under the share repurchase mandate
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Next Day Disclosure Return
- Voluntary announcement - latest update on the cooperation with rejuven
Follow Cutia Therapeutics into a list and get an email when it puts out news.
Follow Cutia Therapeutics